Terms: = Colorectal cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5
1391 results:
1. Prognostic implications of immunohistochemistry in patients with endometrial cancer.
Anca-Stanciu MB; Manu A; Olinca MV; Coroleucă BC; Comandaşu DE; Coroleucă CA; Maier C; Brătilă E
Rom J Morphol Embryol; 2024; 65(2):185-193. PubMed ID: 39020532
[TBL] [Abstract] [Full Text] [Related]
2. Exome Sequencing Identifies Carriers of the Autosomal Dominant cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations.
Samadder NJ; Gay E; Lindpere V; Bublitz ML; Bandel LA; Armasu SM; Vierkant RA; Ferber MJ; Klee EW; Larson NB; Kruisselbrink TM; Egan JB; Kemppainen JL; Bidwell JS; Anderson JL; McAllister TM; Walker TS; Kunze KL; Golafshar MA; Klint MA; Presutti RJ; Bobo WV; Sekulic A; Summer-Bolster JM; Willman CL; Lazaridis KN
JCO Precis Oncol; 2024 Jul; 8():e2400106. PubMed ID: 39013133
[TBL] [Abstract] [Full Text] [Related]
3. Attenuated adenomatous polyposis with msh6 variation: Two case reports.
Ha GW; Lee MR; Ahn AR; Chung MJ; Kim KM
Medicine (Baltimore); 2024 Jul; 103(27):e38791. PubMed ID: 38968511
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of clinical characteristics of mismatch repair status in colorectal cancer: a multicenter retrospective study.
Mao J; He Y; Chu J; Hu B; Yao Y; Yan Q; Han S
Int J Colorectal Dis; 2024 Jul; 39(1):100. PubMed ID: 38967814
[TBL] [Abstract] [Full Text] [Related]
5. Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer.
Kayhanian H; Cross W; van der Horst SEM; Barmpoutis P; Lakatos E; Caravagna G; Zapata L; Van Hoeck A; Middelkamp S; Litchfield K; Steele C; Waddingham W; Patel D; Milite S; Jin C; Baker AM; Alexander DC; Khan K; Hochhauser D; Novelli M; Werner B; van Boxtel R; Hageman JH; Buissant des Amorie JR; Linares J; Ligtenberg MJL; Nagtegaal ID; Laclé MM; Moons LMG; Brosens LAA; Pillay N; Sottoriva A; Graham TA; Rodriguez-Justo M; Shiu KK; Snippert HJG; Jansen M
Nat Genet; 2024 Jul; 56(7):1420-1433. PubMed ID: 38956208
[TBL] [Abstract] [Full Text] [Related]
6. Tumor-infiltrating lymphocytes, PD-L1, and MMR-deficiency combined characterization may identify subgroups of rectal cancer patients who would benefit from immunotherapy.
Giatromanolaki A; Kavazis C; Gkegka AG; Kouroupi M; Tsaroucha A; Pitiakoudis M; Koukourakis MI
Immunobiology; 2023 Nov; 228(6):152756. PubMed ID: 38860277
[TBL] [Abstract] [Full Text] [Related]
7. Prevalence of Potentially Pathogenic Germline Variants Among Adult Patients in the Philippines With Solid Malignancies Who Underwent Tumor Genomic Profiling.
Franco PI; Andal JJ; Ang DC; Que FV
JCO Glob Oncol; 2024 Jun; 10():e2400019. PubMed ID: 38843470
[TBL] [Abstract] [Full Text] [Related]
8. Functional analysis of MMR gene VUS from potential Lynch syndrome patients.
Mahdouani M; Zhuri D; Sezginer Guler H; Hmida D; Sana M; Azaza M; Ben Said M; Masmoudi S; Hmila F; Youssef S; Ben Sghaier R; Brieger A; Zeuzem S; Saad A; Gurkan H; Yalcintepe S; Gribaa M; Plotz G
PLoS One; 2024; 19(6):e0304141. PubMed ID: 38843250
[TBL] [Abstract] [Full Text] [Related]
9. Assessing Mismatch Repair Expression by Immunohistochemistry in colorectal Adenocarcinoma -Insight from a Tertiary Care Centre.
Lakhe R; Doshi R; Doshi P; Patil A; Nimbargi R
Gulf J Oncolog; 2024 May; 1(45):35-41. PubMed ID: 38774931
[TBL] [Abstract] [Full Text] [Related]
10. Delineating genotype and parent-of-origin effect on the phenotype in msh6-associated Lynch syndrome.
van der Werf-'t Lam AS; Rodriguez-Girondo M; Villasmil M; Tops CM; van Hest L; Gille HJP; Duijkers FAM; Wagner A; Eikenboom E; Letteboer TGW; de Jong MM; Bajwa-Ten Broeke SW; Bleeker F; Gomez Garcia EB; Dominguez-Valentin M; Møller P; Suerink M; Nielsen M
Genes Chromosomes Cancer; 2024 May; 63(5):e23237. PubMed ID: 38722212
[TBL] [Abstract] [Full Text] [Related]
11. The Relationship of Microsatellite Instability with BRAF and p53 Mutations and Histopathological Parameters in colorectal Adenocarcinoma.
Gündoğar Ö; Bektaş S; Yıldırım E; Gönüllü D
Ann Ital Chir; 2024; 95(2):181-191. PubMed ID: 38684491
[TBL] [Abstract] [Full Text] [Related]
12. Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer.
Jakab A; Patai ÁV; Darvas M; Tormássi-Bély K; Micsik T
Pathol Oncol Res; 2024; 30():1611574. PubMed ID: 38645565
[No Abstract] [Full Text] [Related]
13. Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome.
Grindedal EM; Zucknick M; Stormorken A; Rønne E; Tandstad NM; Isaacs WB; Axcrona K; Mæhle L
Prostate; 2024 Jul; 84(10):945-953. PubMed ID: 38629217
[TBL] [Abstract] [Full Text] [Related]
14. Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome.
Ito T; Yamaguchi T; Kumamoto K; Suzuki O; Chika N; Kawakami S; Nagai T; Igawa T; Fujiyoshi K; Akagi Y; Arai T; Akagi K; Eguchi H; Okazaki Y; Ishida H
Int J Clin Oncol; 2024 Jul; 29(7):953-963. PubMed ID: 38615286
[TBL] [Abstract] [Full Text] [Related]
15. [Expression of immune checkpoints PD-L1, CTLA4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
[TBL] [Abstract] [Full Text] [Related]
16. Mitotic abnormalities precede microsatellite instability in lynch syndrome-associated colorectal tumourigenesis.
Pussila M; Laiho A; Törönen P; Björkbacka P; Nykänen S; Pylvänäinen K; Holm L; Mecklin JP; Renkonen-Sinisalo L; Lehtonen T; Lepistö A; Linden J; Mäki-Nevala S; Peltomäki P; Nyström M
EBioMedicine; 2024 May; 103():105111. PubMed ID: 38583260
[TBL] [Abstract] [Full Text] [Related]
17. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
Ercan AB; Aronson M; Fernandez NR; Chang Y; Levine A; Liu ZA; Negm L; Edwards M; Bianchi V; Stengs L; Chung J; Al-Battashi A; Reschke A; Lion A; Ahmad A; Lassaletta A; Reddy AT; Al-Darraji AF; Shah AC; Van Damme A; Bendel A; Rashid A; Margol AS; Kelly BL; Pencheva B; Heald B; Lemieux-Anglin B; Crooks B; Koschmann C; Gilpin C; Porter CC; Gass D; Samuel D; Ziegler DS; Blumenthal DT; Kuo DJ; Hamideh D; Basel D; Khuong-Quang DA; Stearns D; Opocher E; Carceller F; Baris Feldman H; Toledano H; Winer I; Scheers I; Fedorakova I; Su JM; Vengoechea J; Sterba J; Knipstein J; Hansford JR; Gonzales-Santos JR; Bhatia K; Bielamowicz KJ; Minhas K; Nichols KE; Cole KA; Penney L; Hjort MA; Sabel M; Gil-da-Costa MJ; Murray MJ; Miller M; Blundell ML; Massimino M; Al-Hussaini M; Al-Jadiry MF; Comito MA; Osborn M; Link MP; Zapotocky M; Ghalibafian M; Shaheen N; Mushtaq N; Waespe N; Hijiya N; Fuentes-Bolanos N; Ahmad O; Chamdine O; Roy P; Pichurin PN; Nyman P; Pearlman R; Auer RC; Sukumaran RK; Kebudi R; Dvir R; Raphael R; Elhasid R; McGee RB; Chami R; Noss R; Tanaka R; Raskin S; Sen S; Lindhorst S; Perreault S; Caspi S; Riaz S; Constantini S; Albert S; Chaleff S; Bielack S; Chiaravalli S; Cramer SL; Roy S; Cahn S; Penna S; Hamid SA; Ghafoor T; Imam U; Larouche V; Magimairajan Issai V; Foulkes WD; Lee YY; Nathan PC; Maruvka YE; Greer MC; Durno C; Shlien A; Ertl-Wagner B; Villani A; Malkin D; Hawkins C; Bouffet E; Das A; Tabori U
Lancet Oncol; 2024 May; 25(5):668-682. PubMed ID: 38552658
[TBL] [Abstract] [Full Text] [Related]
18. Mismatch repair protein deficiency and its implications on distant metastasis in colorectal cancer: A comprehensive analysis.
Fan C; Fang C; Wang W; Lv Z; Zhang X; Long F; Jiang Z; Li Y; Zhang H; Zhou ZG; Wang C; Sun XF
Cancer Med; 2024 Apr; 13(7):e6994. PubMed ID: 38545852
[TBL] [Abstract] [Full Text] [Related]
19. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
[TBL] [Abstract] [Full Text] [Related]
20. Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centre.
Evans DG; Green K; Burghel GJ; Forde C; Lalloo F; Schlecht H; Woodward ER
Fam Cancer; 2024 Jun; 23(2):187-195. PubMed ID: 38478259
[TBL] [Abstract] [Full Text] [Related]
[Next]